View E-Mail in Browser

Weekly News

28 May 2024


Abstract submission is open for the ESCMID/ASM Conference 2024

You can now submit your abstract for this interdisciplinary summit that pledges to tackle the growing threat of AMR, as well as to explore opportunities and outline essential criteria for advancing antimicrobial drug development. Our programme committee features distinguished experts spanning academia, industry, and governmental organisations who work in drug development and AMR.




JUN ’24

Location   Utrecht
Category   Deadline

Summer School 2024 registration


JUN ’24

Location   Porto
Category   Deadline

Abstract submission for ESCMID/ASM Conference


JUL ’24

Category   Deadline

Study Group Research Grant application


Science & Research


Join the ESGEM working group on AMR

ESGEM, in partnership with EUCAST, is launching a new working group on AMR (ESGEM-AMR), to develop standards for interpreting AMR genotypes. In line with EUCAST guidance for interpreting lab phenotypes into clinical categories of S/I/R, we want to define the “AMR rules” for interpreting genotypes as wildtype/non-wildtype and S/I/R. Interested collaborators are encouraged to register for the working group through the sign-up form by 2 June 2024.


Call for ESCMID Ethics Advisory Committee member 2024

We are opening a call for a new member of the ESCMID Ethics Advisory Committee (EEAC), with duration of term until April 2028 (after ESCMID Global). The EEAC is an independent body with the main duty of counselling on specific ethical issues related to ESCMID funded-research projects and scientific behaviour of members in matters related to the society activities. Check out the role description and how to apply on our website.




Last week to register for the ESCMID Summer School 2024

Don't miss this transformative opportunity to elevate your career:

Gain hands-on experience and practical skills in Innovative Workshops, where you'll dive into real-world applications and case studies; engage in Fireplace Sessions for intimate discussions with leading experts on contemporary issues and future directions; showcase your research in Student Presentations to a knowledgeable audience; network with peers and mentors in Social Events.


Update your knowledge about the management of common infectious diseases in Older Adults

Management of elderly patients with infections is challenging. The elderly may present atypically, have a higher risk for specific pathogens, different PK/PD, and poorer outcomes. In this course, we will discuss the management of several common infections in the elderly, providing a clinical approach to these infections.

The registration for this online course will be open until 1 June 2024.


Ecraid Training Modules on Adaptive Clinical Trial Designs – New module coming soon

The next module of the Adaptive Clinical Trial Designs course – Module 3: “Group sequential designs and sample size re-estimation” – will be available as of 31 May 2024. It introduces group sequential designs, starting with a brief summary of the underpinning theory and computations. It goes on to contrast trials designed as group sequential tests with trials that employ sample size re-estimation.


Congress & Events


ESCMID Global 2024: real time session graphics by Frank Flöthmann

Renowned German illustrator Frank Flöthmann drew amazing graphical abstracts for some of our most interesting ESCMID Global 2024 sessions and Keynote lectures. Check out these stunning creations crafted in real time! We will release weekly the timelapses of the drawings on our YouTube channel.


Guidelines & Journals


ESCMID guideline under public consultation

The draft document “ESCMID/EUCIC clinical guidelines on preoperative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery” is available for public consultation. ESCMID members wishing to participate can contact us and will then receive the confidential document to comment on substantive content.

The deadline to provide feedback is 11 June 2024.



Which trial do we need? Gown and glove use versus standard precautions for patients colonised or infected with MRSA or VRE